Compare FINV & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FINV | IART |
|---|---|---|
| Founded | 2007 | 1989 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | N/A | 1995 |
| Metric | FINV | IART |
|---|---|---|
| Price | $5.17 | $13.48 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 7 |
| Target Price | $11.55 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.9M | 849.4K |
| Earning Date | 11-19-2025 | 10-30-2025 |
| Dividend Yield | ★ 5.44% | N/A |
| EPS Growth | ★ 27.76 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | ★ $1,969,555,571.00 | $1,642,966,000.00 |
| Revenue This Year | $5.54 | $3.26 |
| Revenue Next Year | N/A | $2.71 |
| P/E Ratio | $3.51 | ★ N/A |
| Revenue Growth | ★ 8.81 | 4.99 |
| 52 Week Low | $4.70 | $10.87 |
| 52 Week High | $11.08 | $27.13 |
| Indicator | FINV | IART |
|---|---|---|
| Relative Strength Index (RSI) | 42.34 | 54.44 |
| Support Level | $5.12 | $13.27 |
| Resistance Level | $5.40 | $14.35 |
| Average True Range (ATR) | 0.21 | 0.58 |
| MACD | 0.07 | 0.13 |
| Stochastic Oscillator | 42.31 | 53.35 |
FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.